Several studies show that GCase enzyme activity is reduced in carriers of GBA1 mutations with PD compared to controls, and even reduced in some idiopathic PD (iPD) cases without known GBA1 mutations, suggesting GCase might play a broader role [18]. The gene discussed is GBA1; the disease is Parkinson disease.